Getinge finalizes acquisition of Pulsion Medical Systems

Getinge has secured 78.55% of the outstanding shares in Pulsion Medical Systems.
All conditions precedent stipulated in the offer document have been met and the
transaction was completed yesterday. Pulsion will be consolidated in Getinge’s
accounts as of March 1 2014.

As communicated earlier, Getinge has issued a public tender offer to acquire all
shares in Pulsion Medical Systems SE (“Pulsion”) listed on the German Stock
Exchange (Deutsche Börse) against payment of EUR 16.90 per share in cash.

All conditions precedent stipulated in the offer document have been met and the
transaction was completed yesterday. The preparation of the Domination and
Profit and Loss Transfer Agreement has thus been initiated. Getinge is expected
to take control over Pulsion in due course.
According to German Law, the offer can still be accepted by the remaining
shareholders until 3 March 2014.

Further information to the public tender offer is set forth in the offer
document and is available on www.maquet.com/pulsion-angebot.

For further information please contact:

Ulf Grunander
CFO, Getinge Group
Phone: +46 10 335 55 80
Email: ulf.grunander@getinge.com

GETINGE GROUP is a leading global provider of products and systems that
contribute to quality enhancement and cost efficiency within healthcare and life
sciences. We operate under the three brands of ArjoHuntleigh, GETINGE and
MAQUET. ArjoHuntleigh focuses on patient mobility and wound management
solutions. GETINGE provides solutions for infection control within healthcare
and contamination prevention within life sciences. MAQUET specializes in
solutions, therapies and products for surgical interventions, interventional
cardiology and intensive care.
The information is such that Getinge AB must disclose in accordance with the
Swedish Securities Market Act and/or the Financial Instruments Trading Act